Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension
NCT ID: NCT01669213
Last Updated: 2012-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2012-08-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ondansetron in the Prevention of Hypotension in Patients Undergoing Spinal Anesthesia
NCT03973411
Association of 5-HT3 Receptor Gene Polymorphism With the Efficiency of Ondansetron for Postoperative Nausea and Vomiting
NCT01657786
5-HT3 Antagonists (Antiemetics) and Cardiac Safety
NCT02436798
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
NCT03297021
The Effects of Ondansetron on Brain Function
NCT02460341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ramosetron 0.3 mg
preparation of ramosetron 0.3 mg
ramosetron
before 5 minutes spinal anesthesia, injection of ramosetron 0.3 mg
ondansetron 8 mg
preparation of ondansetron 8mg
ondansetron
before 5 minutes spinal anesthesia, injection of ondansetron 8 mg
ondansetron 4 mg
preparation of ondansetron 4mg
ondansetron
before 5 minutes spinal anesthesia, injection of ondansetron 4 mg
non 5-HT3 receptor antagonist
preparation of normal saline 5 ml
placebo
before 5 minutes spinal anesthesia, injection of normal saline 5 ml
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ramosetron
before 5 minutes spinal anesthesia, injection of ramosetron 0.3 mg
ondansetron
before 5 minutes spinal anesthesia, injection of ondansetron 8 mg
ondansetron
before 5 minutes spinal anesthesia, injection of ondansetron 4 mg
placebo
before 5 minutes spinal anesthesia, injection of normal saline 5 ml
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wonsik Ahn
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WSAhn_ramosetron_hypotension
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.